ClinVar Miner

Submissions for variant NM_006218.4(PIK3CA):c.1637A>T (p.Gln546Leu)

dbSNP: rs397517201
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Clinical Genomics Laboratory, Washington University in St. Louis RCV005251518 SCV005902205 likely pathogenic PIK3CA related overgrowth syndrome 2024-06-01 criteria provided, single submitter clinical testing A PIK3CA c.1637A>T (p.Gln546Leu) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported as a somatic variant in 9 cases in the cancer database COSMIC (Genomic Mutation ID: COSV55877455). It is absent from the general population (gnomAD v4.1.0), indicating it is not a common variant. This variant resides within the helical domain of the p110alpha catalytic subunit of PIK3CA and constitutes a mutational hotspot (Madsen R et al., PMID: 30197175; Keppler-Noreuil KM et al., PMID: 25557259; Gymnopoulos M et al., PMID: 17376864). A PIK3CA c.1637A>T (p.Gln546Leu) variant has been annotated as activating and shown to increased transformation ability in two different cell lines (Ng PKS et al., PMID: 29533785). Additionally, the PIK3CA gene is defined by the ClinGen Brain Malformations expert panel as a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (Lai A et al., PMID: 35997716). Multiple variants in the same codon, p.Gln546Arg, p.Gln546Glu, p.Gln546His, p.Gln546Lys, and p.Gln546Pro, have been reported and are considered pathogenic (ClinVar Variation IDs: 45466, 13654, 376491, 13657, 375898; Mirzaa G et al., PMID: 27631024). A large number of PI3K/AKT pathway inhibitors are currently under clinical study in both PROS disorders and cancer (Jin N et al., PMID: 34779417; Venot Q et al., PMID: 29899452; Parker VER et al., PMID: 30270358)Based on available information and an internally developed protocol informed by the ACMG/AMP guidelines for variant interpretation and gene-specific practices from the ClinGen Criteria Specification Registry (Leon-Quintero FZ et al., PMID: 39434542), the PIK3CA c.1637A>T (p.Glu546Leu) variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.